BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
Gentex Corporation delivered a mixed 2025, with Q4 results buoyed by its Vox acquisition and improved core profitability, while tariffs on China exports continued to pressure sales. The automotive tech supplier provided a roadmap focused on advanced mirrors, sensing, and new electrochromic applications like dimmable visors.
The digital financial services giant SoFi reported blockbuster Q4 2025 results, surpassing $1 billion in quarterly revenue for the first time. Fueled by explosive member growth and a booming tech platform, CEO Anthony Noto outlined an ambitious roadmap into crypto, stablecoins, and AI, signaling a new phase of aggressive expansion beyond traditional banking.
A landmark agreement between the U.S. Department of Commerce and the Cameco-Westinghouse joint venture aims to catalyze over $80 billion in new nuclear reactor construction by 2030, bolstering Western energy security and reducing reliance on Russian nuclear fuel.
GSK makes a dual strategic move, acquiring RAPT Therapeutics for its food allergy portfolio and securing broader European approval for its RSV vaccine Arexvy, reinforcing its focus on immunology and respiratory health.
Axos Financial (NYSE: AX) reported strong fiscal Q2 2026 results, with net income jumping to $128.4 million. Driven by broad-based loan growth and contributions from Verdant Commercial Capital, the digital bank highlighted expanding margins, improved credit metrics, and a confident outlook for continued mid-teens annual loan growth.
Huntington Bancshares has finalized its merger with Cadence Bank, a move that significantly extends its regional footprint into Texas and the Southern U.S. and reshapes its competitive standing.
Analyst firm Benchmark increased its price target for specialty food distributor The Chefs' Warehouse (CHEF) to $84, maintaining a Buy rating. The move follows strong operational performance, including domestic acquisitions and double-digit international growth in the Middle East.
Despite a recent sales miss, AutoZone (AZO) is doubling down on store growth, drawing mixed analyst reactions. JPMorgan remains bullish with an $4,100 price target, while Wolfe Research downgraded the stock, highlighting the complex landscape for the auto parts retailer.
Africa's largest conglomerate secures a strategic gas supply agreement with Nigeria's state oil firm, a key move supporting national ambitions to leverage vast gas reserves for industrial growth and investment.
Fintech startup Jelou has raised $10 million in Series A funding to scale its AI-driven conversational banking platform, Brain, from Latin America to the U.S., enabling payments, verification, and credit services directly within messaging apps.
Sanofi reports a pivotal Phase 3 win for its investigational therapy venglustat in a rare neurological disorder, alongside positive EU regulatory news for Rezurock and progress for amlitelimab, signaling a strategic shift toward high-value specialty medicines.
Following a strategic partnership with Singapore's GIC, Realty Income (NYSE: O) is poised for a transformative year. Analysts forecast further international growth, portfolio diversification into new property verticals, and a potential rebound in share performance as catalysts align.
LGI Homes deepens its California footprint with a new solar-equipped community near Modesto, bundling high-value upgrades to attract buyers. While the move underscores a strategic shift towards energy efficiency, analysts question its immediate impact on the homebuilder's strained margins and growth trajectory.
Financial disclosures show the growing religious instruction nonprofit LifeWise Academy increased its fundraising haul last year while its net profit fell, as it expands its reach into public schools across Ohio and nationwide.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
ABIVAX (NASDAQ:ABVX) shares have skyrocketed over 2000% in recent months, fueled by speculation of an Eli Lilly buyout and promising clinical data for its lead drug. CEO Marc De Garidel has publicly dismissed the acquisition rumors as 'noise,' redirecting focus to the company's financing needs and advancing therapeutic programs.
Kuya Silver reports a record quarterly production haul from its Bethania silver mine alongside accelerated underground development, drawing investor focus. However, a premium valuation against a backdrop of ongoing losses presents a complex picture for the junior miner.
Chinese electric vehicle maker NIO reports a near-doubling of January deliveries year-over-year, surpassing one million cumulative vehicles. The company is pushing into new markets in Europe and Asia while rolling out a major driver-assistance system upgrade to its existing fleet, even as it navigates subsidy reductions and intensifying competition at home.
D-Wave Quantum solidifies its dual-platform quantum computing approach through the acquisition of Quantum Circuits Inc. and the launch of a major Florida R&D hub, backed by new multi-million dollar commercial and academic agreements.
